Kavango Resources to enter “Year of Discovery” on a high after delivering its most exciting KSZ results to date
In an early Christmas present to investors, Kavango Resources (LSE:KAV) has revealed the strongest evidence yet that it could be on track to hit vast amounts of metal mineralisation at its Kalahari Suture Zone (“KSZ”) project. Late last Friday, the explorer not only confirmed the presence of its major conductor drill target at the Botswana-based licences, but also that the conductor is stronger that it had previously modelled.
With drilling set to re-commence right away in the New Year, Kavango has now done everything it can to kick off its self-described “Year of Discovery” with as big a bang as possible.
Speaking to ShareTalk, Kavango’s chief executive Ben Turney highlighted the concrete potential that Kavango and Spectral’s latest work has solidified:
Speaking to ShareTalk, Kavango’s chief executive Ben Turney highlighted the concrete potential that Kavango and Spectral’s latest work has solidified:
“Our first hole at the Great Red Spot was a data gathering exercise to prepare us for mobilizing to B1, the conductor that we are now drilling.
Through our modelling, we had already seen the potential for B1 to stretch across stacked layers of prospective rock, a very promising addition to the target’s existing Karoo-aged potential. Now, we have taken the first step towards proving this with evidence, with the new hole presenting a similar stratigraphy.
With B1 providing a much stronger conductance reading than before, and the indications the drill is right on track to hit the centre of the target, Kavango is in a very exciting position as we enter the New Year.”
Listen On
Also Listen
-
Zak Mir talks to Charles Dickson, CEO of Roadside Real Estate
We spoke with Charles Dixon, CEO of Roadside Real Estate, to unpack the company' -
Zak Mir Speaks with Fiinu CEO Dr. Marko Sjoblom on New Strategic Partnership
Zak Mir caught up with Dr. Marko Sjoblom, Chief Executive Officer of Fiinu Plc, -
Tim McCarthy, Chief Executive Officer of ImmuPharma PLC talks to Zak Mir
Zak Mir talks to Tim McCarthy, CEO of Immupharma, the speciality biopharmaceutic -
Zak Mir talks to Ippolito Cattaneo, Chief Executive Officer of Ajax Resources Plc
Zak Mir talks to Ippolito Cattaneo, CEO of Ajax Resources, in the wake of this w